Home Applications 020301 Application 020301
Type NDA
Sponsor JANSSEN PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ORTHO-CEPT DESOGESTREL; ETHINYL ESTRADIOL TABLET;ORAL-21 0.15MG;0.03MG No No 002 ORTHO-CEPT DESOGESTREL; ETHINYL ESTRADIOL TABLET;ORAL-28 0.15MG;0.03MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020301-001 ORTHO-CEPT DESOGESTREL; ETHINYL ESTRADIOL 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-21 RLD 1992-12-14 N020301-002 ORTHO-CEPT DESOGESTREL; ETHINYL ESTRADIOL 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-28 RLD 1992-12-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020301-001 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-21 RLD 1992-12-14 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020301-002 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-28 RLD 1992-12-14 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020301-001 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-21 RLD 1992-12-14 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N020301-002 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-28 RLD 1992-12-14 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020301-001 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-21 RLD 1992-12-14 e64feba35796…2022-09-29 23:25 UTC 2022-09 N020301-002 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-28 RLD 1992-12-14 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020301-001 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-21 RLD 1992-12-14 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020301-002 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-28 RLD 1992-12-14 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N020301-001 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-21 RLD 1992-12-14 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N020301-002 ORTHO-CEPT 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL-28 RLD 1992-12-14 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 49421 SUPPL 2017-08-15 49298 SUPPL 2017-08-09 12429 SUPPL 2015-12-02 2318 SUPPL 2015-12-02 24755 SUPPL 2013-10-04 24754 SUPPL 2013-10-04 12427 SUPPL 2013-10-04 2317 SUPPL 2013-10-04 2316 SUPPL 2013-10-04 12428 SUPPL 2012-07-13 2315 SUPPL 2012-06-20